177 related articles for article (PubMed ID: 31502160)
1. High-Parameter Immune Profiling with CyTOF.
Sahaf B; Rahman A; Maecker HT; Bendall SC
Methods Mol Biol; 2020; 2055():351-368. PubMed ID: 31502160
[TBL] [Abstract][Full Text] [Related]
2. Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry.
Schulz AR; Mei HE
Methods Mol Biol; 2019; 1989():93-108. PubMed ID: 31077101
[TBL] [Abstract][Full Text] [Related]
3. Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC.
Sahaf B; Pichavant M; Lee BH; Duault C; Thrash EM; Davila M; Fernandez N; Millerchip K; Bentebibel SE; Haymaker C; Sigal N; Del Valle DM; Ranasinghe S; Fayle S; Sanchez-Espiridion B; Zhang J; Bernatchez C; Wu CJ; Wistuba II; Kim-Schulze S; Gnjatic S; Bendall SC; Song M; Thurin M; Lee JJ; Maecker HT; Rahman A
Clin Cancer Res; 2021 Sep; 27(18):5062-5071. PubMed ID: 34266889
[TBL] [Abstract][Full Text] [Related]
4. A CD45-based barcoding approach to multiplex mass-cytometry (CyTOF).
Lai L; Ong R; Li J; Albani S
Cytometry A; 2015 Apr; 87(4):369-74. PubMed ID: 25645694
[TBL] [Abstract][Full Text] [Related]
5. Live Cell Barcoding for Efficient Analysis of Small Samples by Mass Cytometry.
Wagar LE
Methods Mol Biol; 2019; 1989():125-135. PubMed ID: 31077103
[TBL] [Abstract][Full Text] [Related]
6. Stabilizing Antibody Cocktails for Mass Cytometry.
Schulz AR; Baumgart S; Schulze J; Urbicht M; Grützkau A; Mei HE
Cytometry A; 2019 Aug; 95(8):910-916. PubMed ID: 31058420
[TBL] [Abstract][Full Text] [Related]
7. Automation of sample preparation for mass cytometry barcoding in support of clinical research: protocol optimization.
Nassar AF; Wisnewski AV; Raddassi K
Anal Bioanal Chem; 2017 Mar; 409(9):2363-2372. PubMed ID: 28124752
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
Maby P; Corneau A; Galon J
Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
[TBL] [Abstract][Full Text] [Related]
9. Standardization and quality control for high-dimensional mass cytometry studies of human samples.
Kleinsteuber K; Corleis B; Rashidi N; Nchinda N; Lisanti A; Cho JL; Medoff BD; Kwon D; Walker BD
Cytometry A; 2016 Oct; 89(10):903-913. PubMed ID: 27575385
[TBL] [Abstract][Full Text] [Related]
10. Harmonized analysis of PBMC by mass cytometry.
Schulz AR; Rademacher J; Bockhorn V; Mei HE
Methods Cell Biol; 2024; 186():107-130. PubMed ID: 38705596
[TBL] [Abstract][Full Text] [Related]
11. High-Dimensional Single-Cell Analysis with Mass Cytometry.
Brodie TM; Tosevski V
Curr Protoc Immunol; 2017 Aug; 118():5.11.1-5.11.25. PubMed ID: 28762483
[TBL] [Abstract][Full Text] [Related]
12. Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system.
Bagwell CB; Hunsberger B; Hill B; Herbert D; Bray C; Selvanantham T; Li S; Villasboas JC; Pavelko K; Strausbauch M; Rahman A; Kelly G; Asgharzadeh S; Gomez-Cabrero A; Behbehani G; Chang H; Lyberger J; Montgomery R; Zhao Y; Inokuma M; Goldberger O; Stelzer G
Cytometry B Clin Cytom; 2020 Mar; 98(2):146-160. PubMed ID: 31758746
[TBL] [Abstract][Full Text] [Related]
13. Broad Immune Monitoring and Profiling of T Cell Subsets with Mass Cytometry.
Brodie TM; Tosevski V
Methods Mol Biol; 2018; 1745():67-82. PubMed ID: 29476463
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell Mass Cytometry of Archived Human Epithelial Tissue for Decoding Cancer Signaling Pathways.
Scurrah CR; Simmons AJ; Lau KS
Methods Mol Biol; 2019; 1884():215-229. PubMed ID: 30465206
[TBL] [Abstract][Full Text] [Related]
15. Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials.
Gadalla R; Noamani B; MacLeod BL; Dickson RJ; Guo M; Xu W; Lukhele S; Elsaesser HJ; Razak ARA; Hirano N; McGaha TL; Wang B; Butler M; Guidos CJ; Ohashi PS; Siu LL; Brooks DG
Front Oncol; 2019; 9():415. PubMed ID: 31165047
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry and cell activation.
Gavasso S
Methods Mol Biol; 2009; 514():35-46. PubMed ID: 19048212
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads.
Bringeland GH; Bader L; Blaser N; Budzinski L; Schulz AR; Mei HE; Myhr KM; Vedeler CA; Gavasso S
Cytometry A; 2019 Mar; 95(3):314-322. PubMed ID: 30688025
[TBL] [Abstract][Full Text] [Related]
18. Customizing Maxpar Direct Immune Profiling Assay with Additional Surface Marker and Intracellular Cytokine Staining Workflows for Expanded Mass Cytometry Panels.
Petes C; Li SKH; Mujib S; Poulin MM; Saederup N; Quong AA; Loh C
Methods Mol Biol; 2022; 2386():129-145. PubMed ID: 34766269
[TBL] [Abstract][Full Text] [Related]
19. Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry.
Leipold MD; Newell EW; Maecker HT
Methods Mol Biol; 2015; 1343():81-95. PubMed ID: 26420710
[TBL] [Abstract][Full Text] [Related]
20. Systems-Level Immune Monitoring by Mass Cytometry.
Lakshmikanth T; Brodin P
Methods Mol Biol; 2019; 1913():33-48. PubMed ID: 30666597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
